London-based medtech startup Neurofenix has raised $7m (£5.9m) in Sequence A funding led by AlbionVC for US enlargement, hiring and scientific trials.
Neurofenix combines a telemedicine platform with its sensor-based Neuroball machine to supply personalised rehabilitation for folks which were affected by stroke, traumatic mind injury and spinal cord injury.
Sufferers use the Neuroball for the rehabilitation of arm and hand features by way of both video games or monitoring executed by way of its app.
“Neurofenix is poised to revolutionize bodily restoration after a neurological injury, similar to a stroke, traumatic mind injury or spinal cord injury,” stated Andrew, Elder, deputy managing companion, AlbionVC.
Yearly over 100,000 folks within the UK have a stroke at an estimated £3bn value to the NHS plus an additional £4bn in productiveness, incapacity and casual care.
Neurofenix was based in 2016 by CEO Guillem Singla Buxarrais and CTO Dimitrios Athanasiou, graduates of Imperial Faculty London and Entrepreneur First alumni.
Elder added: “With my background as a neurosurgeon, I may see that Neurofenix is positioned to fill a serious hole within the neuro-rehab business.”
Becoming a member of AlbionVC within the spherical had been HTH, InHealth Ventures together with earlier backers of the startup.
Launched in 1996, AlbionVC backs UK early-stage B2B software program and healthcare firms similar to the information analytics platform Black Swan Information and Credit score Kudos.
Digital healthcare has continued to increase for the reason that pandemic. Fellow telehealth platform for pets Vetster not too long ago launched its service within the UK, following a £25m increase.
Discussion about this post